| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 4 | US FAERS | |
| 2 | Lenalidomide | FAERS: 2 | US FAERS | |
| 3 | Oseltamivir | FAERS: 2 | US FAERS | |
| 4 | apixaban | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | osimertinib | FAERS: 2 | US FAERS | |
| 6 | Everolimus | FAERS: 1 | US FAERS | |
| 7 | Methotrexate | FAERS: 1 | US FAERS | |
| 8 | Tacrolimus | FAERS: 1 | US FAERS | |
| 9 | Telbivudine | FAERS: 1 | US FAERS | |
| 10 | Valproic Acid | FAERS: 1 | US FAERS | |
| 11 | ambrisentan | FAERS: 1 | US FAERS | |
| 12 | baricitinib | FAERS: 1 | US FAERS | |
| 13 | carfilzomib | FAERS: 1 | US FAERS | |
| 14 | temsirolimus | FAERS: 1 | US FAERS | |
| 15 | treprostinil | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.